Kathrin TISSOT

Person

Neuried, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody drug conjugates for ablating hematopoietic stem cells
- Patent number 11,357,864
- Issue date Jun 14, 2022
- Novartis AG
- Ben Wen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of providing disease-specific binding molecules and targets
- Patent number 10,202,445
- Issue date Feb 12, 2019
- University of Zurich
- Roger Nitsch
- G01 - MEASURING TESTING
Information Patent Grant
Methods of treating Alzheimer's disease
- Patent number 10,131,708
- Issue date Nov 20, 2018
- University of Zurich
- Roger Nitsch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of providing disease-specific binding molecules and targets
- Patent number 9,828,420
- Issue date Nov 28, 2017
- University of Zurich
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of providing disease-specific binding molecules and targets
- Patent number 9,670,272
- Issue date Jun 6, 2017
- University of Zurich
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of providing disease-specific binding molecules and targets
- Patent number 8,906,367
- Issue date Dec 9, 2014
- University of Zurich
- Roger Nitsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS
- Publication number 20210228731
- Publication date Jul 29, 2021
- Novartis AG
- Anthony Edward BOITANO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS
- Publication number 20190321483
- Publication date Oct 24, 2019
- Novartis AG
- Ben WEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
- Publication number 20190263896
- Publication date Aug 29, 2019
- University of Zurich
- Roger NITSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
- Publication number 20190153082
- Publication date May 23, 2019
- University of Zurich
- Roger NITSCH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of Providing Disease-Specific Binding Molecules and Targets
- Publication number 20180134773
- Publication date May 17, 2018
- University of Zurich
- Roger NITSCH
- G01 - MEASURING TESTING
Information Patent Application
METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
- Publication number 20170283491
- Publication date Oct 5, 2017
- University of Zurich
- Roger NITSCH
- G01 - MEASURING TESTING
Information Patent Application
Method of Providing Disease-Specific Binding Molecules and Targets
- Publication number 20160289310
- Publication date Oct 6, 2016
- University of Zurich
- Roger NITSCH
- G01 - MEASURING TESTING
Information Patent Application
METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
- Publication number 20130216555
- Publication date Aug 22, 2013
- University of Zurich
- Roger NITSCH
- G01 - MEASURING TESTING

Kathrin TISSOT

Person

Patents Grantslast 30 patents

Antibody drug conjugates for ablating hematopoietic stem cells

Method of providing disease-specific binding molecules and targets

Methods of treating Alzheimer's disease

Method of providing disease-specific binding molecules and targets

Method of providing disease-specific binding molecules and targets

Method of providing disease-specific binding molecules and targets

Patents Applicationslast 30 patents

ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS

ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

Method of Providing Disease-Specific Binding Molecules and Targets

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

Method of Providing Disease-Specific Binding Molecules and Targets

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS